BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2976252)

  • 1. Biochemical properties of D1 and D2 dopamine receptors.
    Senogles SE; Amlaiky N; Berger JG; Caron MG
    Adv Exp Med Biol; 1988; 235():33-41. PubMed ID: 2976252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the D2-dopamine receptor binding subunit in several mammalian tissues and species by photoaffinity labeling.
    Amlaiky N; Caron MG
    J Neurochem; 1986 Jul; 47(1):196-204. PubMed ID: 2940337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    Enjalbert A; Bockaert J
    Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and functional characterization of central dopamine receptors.
    Goldstein M; Lew JY; Meller E
    Adv Exp Med Biol; 1988; 235():43-53. PubMed ID: 2976253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P; Niznik HB; Guan HC; Booth G; Ulpian C
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10156-60. PubMed ID: 2574862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of dopamine receptors.
    Bates MD; Gingrich JA; Bunzow JR; Falardeau P; Dearry A; Senogles SE; Civelli O; Caron MG
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):29S-33S. PubMed ID: 2143386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1 and D2 receptor selectivities of agonists and antagonists.
    Seeman P; Ulpian C
    Adv Exp Med Biol; 1988; 235():55-63. PubMed ID: 2976254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent and biotin probes for dopamine receptors: D1 and D2 receptor affinity and selectivity.
    Madras BK; Canfield DR; Pfaelzer C; Vittimberga FJ; Difiglia M; Aronin N; Bakthavachalam V; Baindur N; Neumeyer JL
    Mol Pharmacol; 1990 Jun; 37(6):833-9. PubMed ID: 2141665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deglycosylation and proteolysis of photolabeled D2 dopamine receptors of the porcine anterior pituitary.
    Jarvie KR; Niznik HB
    J Biochem; 1989 Jul; 106(1):17-22. PubMed ID: 2528540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity chromatography of the anterior pituitary D2-dopamine receptor.
    Senogles SE; Amlaiky N; Johnson AL; Caron MG
    Biochemistry; 1986 Feb; 25(4):749-53. PubMed ID: 2938619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland.
    Munemura M; Agui T; Sibley DR
    Endocrinology; 1989 Jan; 124(1):346-55. PubMed ID: 2521206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
    Roseboom PH; Gnegy ME
    Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
    Clagett-Dame M; Schoenleber R; Chung C; McKelvy JF
    Biochim Biophys Acta; 1989 Nov; 986(2):271-80. PubMed ID: 2531613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
    Sunahara RK; Guan HC; O'Dowd BF; Seeman P; Laurier LG; Ng G; George SR; Torchia J; Van Tol HH; Niznik HB
    Nature; 1991 Apr; 350(6319):614-9. PubMed ID: 1826762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo labeling of brain dopamine D2 receptors using the high-affinity specific D2 agonist [3H]CV 205-502.
    Closse A; Camps M; Wanner A; Palacios JM
    Brain Res; 1988 Feb; 440(1):123-32. PubMed ID: 2965955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoaffinity labeling of D-2 dopamine binding subunits from rat striatum, anterior pituitary and olfactory bulb with a new probe, [3H]azidosulpride.
    Redouane K; Sokoloff P; Schwartz JC; Hamdi P; Mann A; Wermuth CG; Roy J; Morgat JL
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1086-92. PubMed ID: 3161508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D1 receptors of the calf parathyroid gland: identification of a ligand binding subunit with lower apparent molecular weight but similar primary structure to neuronal D1-receptors.
    Niznik HB; Jarvie KR; Brown EM
    Biochemistry; 1989 Aug; 28(17):6925-30. PubMed ID: 2531003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ternary complex model. Its properties and application to ligand interactions with the D2-dopamine receptor of the anterior pituitary gland.
    Wreggett KA; De Léan A
    Mol Pharmacol; 1984 Sep; 26(2):214-27. PubMed ID: 6237254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.